These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 149385

  • 1. Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole.
    Oblath RW, Buckley FO, Green RM, Schwartz SI, DeWeese JA.
    Surgery; 1978 Jul; 84(1):37-44. PubMed ID: 149385
    [No Abstract] [Full Text] [Related]

  • 2. Correlation between the effects of aspirin and dipyridamole on platelet function and prevention of intimal hyperplasia in autologous vein grafts.
    Landymore RW, Karmazyn M, MacAulay MA, Sheridan B, Cameron CA.
    Can J Cardiol; 1988 Jul; 4(1):56-9. PubMed ID: 3359354
    [Abstract] [Full Text] [Related]

  • 3. Thrombogenicity of a fibronectin-coated, experimental polytetrafluoroethylene graft.
    Kempczinski RF, Ramalanjaona GR, Douville C, Silberstein EB.
    Surgery; 1987 Apr; 101(4):439-44. PubMed ID: 3563890
    [Abstract] [Full Text] [Related]

  • 4. Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man.
    Goldman MD, Simpson D, Hawker RJ, Norcott HC, McCollum CN.
    Ann Surg; 1983 Dec; 198(6):713-6. PubMed ID: 6227296
    [Abstract] [Full Text] [Related]

  • 5. In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets. Effect of dipyridamole and aspirin.
    Pumphrey CW, Chesebro JH, Dewanjee MK, Wahner HW, Hollier LH, Pairolero PC, Fuster V.
    Am J Cardiol; 1983 Mar 01; 51(5):796-801. PubMed ID: 6219569
    [Abstract] [Full Text] [Related]

  • 6. The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs.
    Kester RC.
    Ann R Coll Surg Engl; 1984 Jul 01; 66(4):241-6. PubMed ID: 6234841
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
    Danese CA, Haimov M.
    Surgery; 1971 Dec 01; 70(6):927-34. PubMed ID: 5124672
    [No Abstract] [Full Text] [Related]

  • 8. Combined arachidonic acid and ADP platelet inhibition maximizes patency of small-diameter vascular grafts.
    Valentin LI, Sicard GA, Freeman MB, Allen BT, McGoff MA, Anderson CB.
    Surgery; 1988 Aug 01; 104(2):178-84. PubMed ID: 3135624
    [Abstract] [Full Text] [Related]

  • 9. Reduction of platelet deposition on vascular grafts using an antiplatelet graft coating technique.
    Allen BT, Sparks RE, Welch MJ, Mason NS, Mathias CJ, Clark RE.
    J Surg Res; 1984 Jan 01; 36(1):80-8. PubMed ID: 6228692
    [Abstract] [Full Text] [Related]

  • 10. Platelet aggregation inhibition in human umbilical vein grafts and negatively charged bovine heterografts.
    Feins RH, Roedersheimer R, Green RM, DeWeese JA.
    Surgery; 1979 Apr 01; 85(4):395-9. PubMed ID: 432801
    [Abstract] [Full Text] [Related]

  • 11. Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
    McCollum CN, Crow MJ, Rajah SM, Kester RC.
    Surgery; 1980 Jun 01; 87(6):668-76. PubMed ID: 6445604
    [Abstract] [Full Text] [Related]

  • 12. Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
    Weselcouch EO, Humphrey WR, Aiken JW.
    J Pharmacol Exp Ther; 1987 Jan 01; 240(1):37-43. PubMed ID: 3543298
    [Abstract] [Full Text] [Related]

  • 13. Antiplatelet agents: rationale and results.
    Kelton JG.
    Clin Haematol; 1983 Feb 01; 12(1):311-54. PubMed ID: 6132693
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of blood flow rates on platelet deposition in PTFE arterial bypass grafts.
    Christenson JT, Megerman J, Hanel KC, L'Italien GJ, Strauss HW, Abbott WM.
    Trans Am Soc Artif Intern Organs; 1981 Feb 01; 27():188-91. PubMed ID: 7331075
    [No Abstract] [Full Text] [Related]

  • 16. Histologic, morphometric, and biochemical evolution of vein bypass grafts in a nonhuman primate model. III. Long-term changes and their modification by platelet inhibition with aspirin and dipyridamole.
    Boerboom LE, Olinger GN, Liu TZ, Rodriguez ER, Ferrans VJ, Kissebah AH.
    J Thorac Cardiovasc Surg; 1990 Mar 01; 99(3):426-32. PubMed ID: 2308360
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
    Lin PH, Bush RL, Yao Q, Lumsden AB, Chen C.
    J Surg Res; 2004 May 01; 118(1):45-52. PubMed ID: 15093716
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of platelet deposition on polytetrafluoroethylene grafts by antiplatelet agents.
    Kon ND, Hansen KJ, Martin MB, Meredith JW, Meredith JH, Cordell AR.
    Surgery; 1984 Nov 01; 96(5):870-3. PubMed ID: 6387989
    [Abstract] [Full Text] [Related]

  • 19. Effects of antiplatelet drugs on platelet function tests.
    Sirridge MS, Shannon R, Willoughby TL, Steele P.
    Mo Med; 1979 Apr 01; 76(4):212-7. PubMed ID: 431521
    [No Abstract] [Full Text] [Related]

  • 20. Ticlopidine versus aspirin and dipyridamole: influence on platelet deposition and three-month patency of polytetrafluoroethylene grafts.
    Hansen KJ, Howe HR, Edgerton TA, Faust KB, Kon ND, Geisinger KR, Meredith JH.
    J Vasc Surg; 1986 Aug 01; 4(2):174-8. PubMed ID: 3735571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.